Portal vein blood flow accounts for 75% of total hepatic blood flow, with the hepatic artery accounting for the remainder. As a result, portal vein occlusion may have significant consequences for ...

Please provide your email address to receive an email when new articles are posted on . Postprocedural imaging showed 10% of patients had new portal vein thrombosis after transarterial ...

A 40-year-old man underwent liver transplantation for cirrhosis related to hepatitis B and C viruses in March 2001. Pneumonia and bacteremia with Klebsiella pneumoniae developed. Seven days after ...

The prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% in decompensated patients, 9% in those with acute ...

Researchers explored the case of a 40-year-old woman with polycythemia vera (PV) who developed a portal vein occlusion 1.5 months postpartum after C-section. As one of the 3 main classic disorders of ...

The treatment of hepatocellular carcinoma with macrovascular invasion, including portal vein tumor thrombus, remains challenging to treat and has poor outcomes. Approximately 20% of patients with ...

A high-density lipoprotein (HDL) subspecies produced by small intestine, which potently shields the endotoxicity of bacterial lipopolysaccharide (LPS), may protect against gut-derived liver injury, ...

Algorithm for blood-based panel of methylated DNA and protein markers to detect early-stage hepatocellular carcinoma with high specificity. This is an ASCO Meeting Abstract from the 2020 ASCO Annual ...

The clinical consequences of PVT are varied. [14] Although some patients remain asymptomatic, blockage of portal vein blood flow can produce ischemic hepatitis; worsening portal hypertension; and, ...